REFERENCES
1. Baldoni S, Del Papa B, De Falco F, et al. Notch1 activation negatively impacts on chronic lymphocytic leukemia outcome and is not correlated to the notch1 and ighv mutational status. Front Oncol 2021;11:668573. 2. Woyach JA. What is the optimal management of older cll patients? Best Pract Res Clin Haematol 2018;31(1):83-89. 3. Woyach JA. Treatment-naive cll: Lessons from phase 2 and phase 3 clinical trials. Blood 2019;134(21):1796-1801. 4. Quinquenel A, Aurran-Schleinitz T, Clavert A, et al. Diagnosis and treatment of chronic lymphocytic leukemia: Recommendations of the french cll study group (filo). Hemasphere 2020;4(5):e473. 5. Vitale C, Montalbano MC, Salvetti C, et al. Autoimmune complications in chronic lymphocytic leukemia in the era of targeted drugs. Cancers (Basel) 2020;12(282). 10.3390/cancers12020282. 6. Singal R, Winfield DA, Greaves M. Bone marrow aplasia in b cell chronic lymphocytic leukaemia: Successful treatment with antithymocyte globulin. J Clin Pathol 1991;44(11):954-956. 7. Zonder JA, Keating M, Schiffer CA. Chronic lymphocytic leukemia presenting in association with aplastic anemia. Am J Hematol 2002;71(4):323-327. 8. Hochman MJ, Martin DB. Coincidence of autoimmune hemolytic anemia and pure red cell aplasia in a patient with cll. Ann Hematol 2021;100(2):579-580. 9. Reinart N, Nguyen PH, Boucas J, et al. Delayed development of chronic lymphocytic leukemia in the absence of macrophage migration inhibitory factor. Blood 2013;121(5):812-821. 10. Wherry EJ. T cell exhaustion. Nat Immunol 2011;12(6):492-499. 11. Forconi F, Moss P. Perturbation of the normal immune system in patients with cll. Blood 2015;126(5):573-581. 12. Lad D, Hoeppli R, Huang Q, et al. Regulatory t-cells drive immune dysfunction in cll. Leuk Lymphoma 2018;59(2):486-489. 13. Wright SJ, Keating MJ. Cyclosporine a in chronic lymphocytic leukemia: Dual anti-leukemic and immunosuppressive role? Leuk Lymphoma 1995;20(1-2):131-136. 14. Zhao X, Zhou K, Jing L, et al. Treatment of t-cell large granular lymphocyte leukemia with cyclosporine a: Experience in a chinese single institution. Leuk Res 2013;37(5):547-551.